Annual report pursuant to Section 13 and 15(d)

GOODWILL AND PURCHASED INTANGIBLE ASSETS

v3.21.2
GOODWILL AND PURCHASED INTANGIBLE ASSETS
 12 Months Ended
Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND PURCHASED INTANGIBLE ASSETS GOODWILL AND PURCHASED INTANGIBLE ASSETS
Goodwill
Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in prior business combinations. We have four reportable segments and six operating segments. The operating segments are determined to be the same as reporting units. The following table presents goodwill carrying value and the movements by reporting unit during the fiscal years ended June 30, 2021 and 2020(1):
(In thousands) Wafer Inspection and Patterning
Global Service and Support (“GSS”)
 Specialty Semiconductor Process PCB and Display Component Inspection Total
Balance as of June 30, 2019 $ 360,615  $ 25,908  $ 821,842  $ 989,918  $ 13,575  $ 2,211,858 
Acquired goodwill 56,180  —  —  —  —  56,180 
Goodwill adjustments 166  —  4,195  29,773  —  34,134 
Goodwill impairment —  —  (144,179) (112,470) —  (256,649)
Foreign currency adjustment (121) —  —  —  —  (121)
Balance as of June 30, 2020 416,840  25,908  681,858  907,221  13,575  2,045,402 
Goodwill disposal from sale of business(2)
—  —  —  (34,250) —  (34,250)
Foreign currency adjustment 20  —  —  —  —  20 
Balance as of June 30, 2021 $ 416,860  $ 25,908  $ 681,858  $ 872,971  $ 13,575  $ 2,011,172 
_________________
(1)No goodwill was assigned to the Other reporting unit, and accordingly is not disclosed in the table above.
(2)Refer to the Non-controlling Interest section of Note 10 “Equity, Long-term Incentive Compensation Plans and Non-Controlling Interest” for more information on the sale of PixCell Medical Technologies Ltd. (“PixCell”).
Goodwill is not subject to amortization but is tested for impairment annually during the third fiscal quarter, as well as whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
We performed the required annual goodwill impairment test as of February 28, 2021, and concluded that goodwill was not impaired. As a result of our qualitative assessment, we determined that it was not necessary to perform the quantitative assessment at this time.
The required annual goodwill impairment tests for our fiscal year ended June 30, 2020 were performed as of February 28, 2020. We completed qualitative assessments for all reporting units and concluded that goodwill was not impaired for the Wafer Inspection and Patterning, Global Service and Support, and Component Inspection reporting units. However, due to the downward revision of the financial outlook for the Specialty Semiconductor Process and PCB and Display reporting units as well as the impact of the elevated risk and macroeconomic slowdown driven by the COVID-19 pandemic, we performed a quantitative goodwill impairment assessment for these two reporting units. As a result of the assessment, we recorded $144.2 million and $112.5 million in impairment charges in the Specialty Semiconductor Process and PCB and Display reporting units, respectively, during the quarter ended March 31, 2020.
Goodwill as of June 30, 2021 and 2020 is net of accumulated impairment losses of $534.2 million, of which $277.6 million was included in the Wafer Inspection and Patterning reporting unit, $144.2 million was included in the Specialty Semiconductor Process reporting unit, and $112.5 million was included in the PCB and Display reporting unit.
Goodwill as of June 30, 2019, is net of accumulated impairment loss of $277.6 million, which was included in the Wafer Inspection and Patterning reporting unit.
There have been no significant events or circumstances affecting the valuation of goodwill subsequent to the assessment performed in the third quarter of the fiscal year ended June 30, 2021. The next annual assessment of goodwill by reporting unit is scheduled to be performed in the third quarter of the fiscal year ending June 30, 2022.
Purchased Intangible Assets
The components of purchased intangible assets as of the dates indicated below were as follows:
(In thousands) As of June 30, 2021 As of June 30, 2020
Category Range of
Useful Lives
(in years)		 Gross
Carrying
Amount		 Accumulated
Amortization and Impairment		 Net
Amount		 Gross
Carrying
Amount		 Accumulated
Amortization and Impairment		 Net
Amount
Existing technology
4-8
 $ 1,382,612  $ 499,219  $ 883,393  $ 1,269,883  $ 342,623  $ 927,260 
Customer relationships
4-9
 305,817  131,386  174,431  305,817  98,754  207,063 
Trade name/trademark
4-7
 117,383  53,493  63,890  117,383  39,216  78,167 
Backlog and other
<1-9
 50,403  49,962  441  50,404  47,215  3,189 
Intangible assets subject to amortization 1,856,215  734,060  1,122,155  1,743,487  527,808  1,215,679 
In-process research and development 63,256  100  63,156  175,834  100  175,734 
Total $ 1,919,471  $ 734,160  $ 1,185,311  $ 1,919,321  $ 527,908  $ 1,391,413 
Purchased intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be fully recoverable. The impairment indicator primarily includes the declines in our operating cash flows from the use of these assets. If the impairment indicators are present, we are required to perform a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to these long-lived assets to their carrying value.
As of February 28, 2021, there were no impairment indicators for purchased intangible assets. As of February 28, 2020, no impairment indicators were present except for intangible assets acquired from the Orbotech Acquisition due to the downward revision of its financial outlook and the impact of the elevated risk and macroeconomic slowdown driven by the COVID- 19 pandemic. We performed the required recoverability test and concluded that there was no impairment based on the assessment.
Amortization expense for purchased intangible assets for the periods indicated below was as follows:
Year Ended June 30,
(In thousands) 2021 2020 2019
Amortization expense - Cost of revenues $ 156,596  $ 145,823  $ 52,387 
Amortization expense - Selling, general and administrative 49,531  74,532  34,992 
Amortization expense - Research and development 125  224  13 
Total $ 206,252  $ 220,579  $ 87,392 
Based on the purchased intangible assets’ gross carrying value recorded as of June 30, 2021, the remaining estimated annual amortization expense is expected to be as follows:
Fiscal Year Ending June 30: Amortization
(In thousands)
2022 $ 209,349 
2023 208,257 
2024 205,740 
2025 193,521 
2026 178,346 
Thereafter 126,942 
Total $ 1,122,155